After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
SOURCE Faruqi & Faruqi, LLP
Cramer says Abiomed is too expensive while Harman was hurt by the strong dollar.
Johnson & Johnson was easy, Cramer says, but other stocks were more problematic.
Trade-Ideas LLC identified Abiomed (ABMD) as a new lifetime high candidate
Stocks with insider trader activity include ABMD, POWI and AOS
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.